duloxetine hydrochloride has been researched along with Aniridia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aberdam, D; Bremond-Gignac, D; Dorot, O; Oved, K; Pichinuk, E; Roux, LN; Zennaro, L | 1 |
1 other study(ies) available for duloxetine hydrochloride and Aniridia
| Article | Year |
|---|---|
The antipsychotropic drug Duloxetine rescues PAX6 haploinsufficiency of mutant limbal stem cells through inhibition of the MEK/ERK signaling pathway.
Topics: Animals; Aniridia; Duloxetine Hydrochloride; Eye Proteins; Haploinsufficiency; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinase Kinases; Ophthalmic Solutions; PAX6 Transcription Factor; Signal Transduction; Stem Cells | 2022 |